January 16, 2015
Detailing on MSD’s insomnia medicine Belsomra (suvorexant) left the strongest impression on physicians in November, according to Anterio Inc.’s “mind share” ranking. The drug, which hit the market in late November, grabbed the top spots in both GP (99 beds...read more